L + ZOL: 9.0%) but a suggestive trend probably due to extremely low number of events.
← all excerpts
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer.
1
—
—